Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 9, 2015, Pages 1254-1261

  Rached, Fabiana ^a,b   Lhomme, Marie ^a   Camont, Laurent ^a   Gomes, Fernando ^b   Dauteuille, Carolane ^a   Robillard, Paul ^a   Santos, Raul D ^b   Lesnik, Philippe ^a   Serrano, Carlos V ^b   John Chapman, M ^a   Kontush, Anatol ^a  

^a INSERM   (France)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acute myocardial infarction; Antioxidative activity; Cholesterol efflux; HDL; Inflammation; Lipidomics

Indexed keywords

APOLIPOPROTEIN A1; C REACTIVE PROTEIN; CARRIER PROTEIN; CHOLESTEROL ESTER; CYTOKINE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 3; INTERLEUKIN 6; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDIC ACID; SECRETORY PHOSPHOLIPASE A2; SERUM AMYLOID A; IL6 PROTEIN, HUMAN; PROTEOME;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL COMPOSITION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; LIPIDOMICS; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; AGED; BLOOD; CASE CONTROL STUDY; CELL LINE; CHEMISTRY; DEFICIENCY; FEMALE; HEART INFARCTION; METABOLISM; MIDDLE AGED; MONOCYTE; PATHOLOGY;

ADULT; AGED; APOLIPOPROTEIN A-I; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL LINE; FEMALE; HUMANS; INTERLEUKIN-6; LIPOPROTEINS, HDL3; LYSOPHOSPHATIDYLCHOLINES; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; PHOSPHATIDIC ACIDS; PROTEOME; SERUM AMYLOID A PROTEIN;

EID: 84934900155     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2015.05.007     Document Type: Article

References (39)

1. M.T. Roe, F.S. Ou, K.P. Alexander, L.K. Newby, J.M. Foody, W.B. Gibler, W.E. Boden, E.M. Ohman, S.C. Smith Jr., and E.D. Peterson Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes Eur. Heart J. 29 2008 2480 2488
2. A. Kontush, and M.J. Chapman High-density Lipoproteins: Structure, Metabolism, Function and Therapeutics 2012 Wiley & Sons New York
3. H. Soran, S. Hama, R. Yadav, and P.N. Durrington HDL functionality Curr. Opin. Lipidol. 23 2012 353 366
4. P.M. Clifton, A.M. Mackinnon, and P.J. Barter Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction J. Lipid Res. 26 1985 1389 1398
5. K. Alwaili, D. Bailey, Z. Awan, S.D. Bailey, I. Ruel, A. Hafiane, L. Krimbou, S. Laboissiere, and J. Genest The HDL proteome in acute coronary syndromes shifts to an inflammatory profile Biochim. Biophys. Acta 2012 1821 405 415
6. M. Riwanto, L. Rohrer, B. Roschitzki, C. Besler, P. Mocharla, M. Mueller, D. Perisa, K. Heinrich, L. Altwegg, A. von Eckardstein, T.F. Luscher, and U. Landmesser Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling Circulation 127 2013 891 904
7. C. Besler, K. Heinrich, L. Rohrer, C. Doerries, M. Riwanto, D.M. Shih, A. Chroni, K. Yonekawa, S. Stein, N. Schaefer, M. Mueller, A. Akhmedov, G. Daniil, C. Manes, C. Templin, C. Wyss, W. Maier, F.C. Tanner, C.M. Matter, R. Corti, C. Furlong, A.J. Lusis, A. von Eckardstein, A.M. Fogelman, T.F. Luscher, and U. Landmesser Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease J. Clin. Invest. 121 2011 2693 2708
8. E.W. Holy, C. Besler, U. Landmesser, T.F. Luscher, and F.C. Tanner Abstract 5486: High density lipoprotein (HDL) from healthy subjects, but not from patients with coronary artery disease, exerts anti-thrombotic effects on human endothelial cells Circulation 120 2009 S1100-a-
9. L. Camont, M.J. Chapman, and A. Kontush Biological activities of HDL subpopulations and their relevance to cardiovascular disease Trends Mol. Med. 17 2011 594 603
10. W.S. Davidson, R.A.G.D. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, and A. Kontush Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function Arterioscler. Thromb. Vasc. Biol. 29 2009 870 876
11. A. Kontush, P. Therond, A. Zerrad, M. Couturier, A. Negre-Salvayre, J.A. de Souza, S. Chantepie, and M.J. Chapman Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities Arterioscler. Thromb. Vasc. Biol. 27 2007 1843 1849
12. R.A. Silva, R. Huang, J. Morris, J. Fang, E.O. Gracheva, G. Ren, A. Kontush, W.G. Jerome, K.A. Rye, and W.S. Davidson Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes Proc. Natl. Acad. Sci. U. S. A. 105 2008 12176 12181
13. A.V. Khera, M. Cuchel, M. de la Llera-Moya, A. Rodrigues, M.F. Burke, K. Jafri, B.C. French, J.A. Phillips, M.L. Mucksavage, R.L. Wilensky, E.R. Mohler, G.H. Rothblat, and D.J. Rader Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N. Engl. J. Med. 364 2011 127 135
14. C.J. Rosenthal, and E.C. Franklin Variation with age and disease of an amyloid A protein-related serum component J. Clin. Invest. 55 1975 746 753
15. Y.A. Carpentier, and O. Scruel Changes in the concentration and composition of plasma lipoproteins during the acute phase response Curr. Opin. Clin. Nutr. Metab. Care 5 2002 153 158
16. A.E. Kavo, L.S. Rallidis, G.C. Sakellaropoulos, S. Lehr, S. Hartwig, J. Eckel, P.I. Bozatzi, M. Anastasiou-Nana, P. Tsikrika, and K.E. Kypreos Qualitative characteristics of HDL in young patients of an acute myocardial infarction Atherosclerosis 220 2012 257 264
17. M. Zeller, D. Masson, M. Farnier, L. Lorgis, V. Deckert, Pais de Barros JP, C. Desrumaux, P. Sicard, J. Grober, D. Blache, P. Gambert, L. Rochette, Y. Cottin, and L. Lagrost High serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarction J. Am. Coll. Cardiol. 50 2007 1948 1955
18. N.S. Shachter Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism Curr. Opin. Lipidol. 12 2001 297 304
19. W. Khovidhunkit, M.S. Kim, R.A. Memon, J.K. Shigenaga, A.H. Moser, K.R. Feingold, and C. Grunfeld Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host J. Lipid Res. 45 2004 1169 1196
20. S. Rashid, T. Watanabe, T. Sakaue, and G.F. Lewis Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity Clin. Biochem. 36 2003 421 429
21. G.F. Lewis, and D.J. Rader New insights into the regulation of HDL metabolism and reverse cholesterol transport Circ. Res. 96 2005 1221 1232
22. A. Zerrad-Saadi, P. Therond, S. Chantepie, M. Couturier, K.-A. Rye, M.J. Chapman, and A. Kontush HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis Arterioscler. Thromb. Vasc. Biol. 29 2009 2169 2175
23. N. Fournier, J.L. Paul, V. Atger, A. Cogny, T. Soni, M. de la Llera-Moya, G. Rothblat, and N. Moatti HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum Arterioscler. Thromb. Vasc. Biol. 17 1997 2685 2691
24. L. Gomez Rosso, M. Lhomme, T. Merono, P. Sorroche, L. Catoggio, E. Soriano, C. Saucedo, V. Malah, C. Dauteuille, L. Boero, P. Lesnik, P. Robillard, M.J. Chapman, F. Brites, and A. Kontush Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation Atherosclerosis 237 2014 652 660
25. J.W. Heinecke The HDL proteome: a marker-and perhaps mediator-of coronary artery disease J. Lipid Res. 50 2009 S167 171
26. B.J. Van Lenten, S.Y. Hama, F.C. de Beer, D.M. Stafforini, T.M. McIntyre, S.M. Prescott, B.N. La Du, A.M. Fogelman, and M. Navab Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures J. Clin. Invest. 96 1995 2758 2767
27. D.R. van der Westhuyzen, L. Cai, M.C. de Beer, and F.C. de Beer SAA promotes cholesterol efflux mediated by SR-BI J. Biol. Chem. 23 2005 23
28. S. Abe-Dohmae, K.H. Kato, Y. Kumon, W. Hu, H. Ishigami, N. Iwamoto, M. Okazaki, C.A. Wu, M. Tsujita, K. Ueda, and S. Yokoyama Serum amyloid A generates high density lipoprotein with cellular lipid in an ABCA1- or ABCA7-dependent manner J. Lipid Res. 47 2006 1542 1550
29. S. Larrede, C.M. Quinn, W. Jessup, E. Frisdal, M. Olivier, V. Hsieh, M.J. Kim, M. Van Eck, P. Couvert, A. Carrie, P. Giral, M.J. Chapman, M. Guerin, and W. Le Goff Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent Arterioscler. Thromb. Vasc. Biol. 29 2009 1930 1936
30. B. Lamarche, S. Rashid, and G.F. Lewis HDL metabolism in hypertriglyceridemic states: an overview Clin. Chim. Acta 286 1999 145 161
31. B. Hansel, P. Giral, E. Nobecourt, S. Chantepie, E. Bruckert, M.J. Chapman, and A. Kontush Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity J. Clin. Endocrinol. Metab. 89 2004 4963 4971
32. G.A. Coetzee, A.F. Strachan, D.R. van der Westhuyzen, H.C. Hoppe, M.S. Jeenah, and F.C. de Beer Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition J. Biol. Chem. 261 1986 9644 9651
33. V.G. Cabana, J.R. Lukens, K.S. Rice, T.J. Hawkins, and G.S. Getz HDL content and composition in acute phase response in three species: Triglyceride enrichment of HDL a factor in its decrease J. Lipid Res. 37 1996 2662 2674
34. R. Nijmeijer, W.K. Lagrand, A. Baidoshvili, Y.T. Lubbers, W.T. Hermens, C.J. Meijer, C.A. Visser, C.E. Hack, and H.W. Niessen Secretory type II phospholipase A(2) binds to ischemic myocardium during myocardial infarction in humans Cardiovasc. Res. 53 2002 138 146
35. Z. Mallat, P.G. Steg, J. Benessiano, M.L. Tanguy, K.A. Fox, J.P. Collet, O.H. Dabbous, P. Henry, K.F. Carruthers, A. Dauphin, C.S. Arguelles, J. Masliah, B. Hugel, G. Montalescot, J.M. Freyssinet, B. Asselain, and A. Tedgui Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes J. Am. Coll. Cardiol. 46 2005 1249 1257
36. G. Schmitz, and K. Ruebsaamen Metabolism and atherogenic disease association of lysophosphatidylcholine Atherosclerosis 208 2010 10
37. B. Haidar, S. Mott, B. Boucher, C.Y. Lee, M. Marcil, and J. Genest Jr. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts J. Lipid Res. 42 2001 249 257
38. M. Nazari, M. Kurdi, and H. Heerklotz Classifying surfactants with respect to their effect on lipid membrane order Biophys. J. 102 2012 498 506
39. S.E. Nissen, T. Tsunoda, E.M. Tuzcu, P. Schoenhagen, C.J. Cooper, M. Yasin, G.M. Eaton, M.A. Lauer, W.S. Sheldon, C.L. Grines, S. Halpern, T. Crowe, J.C. Blankenship, and R. Kerensky Effect of recombinant APOA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial JAMA 290 2003 2292 2300